Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Oxidative stress-related signaling pathways" refers to a collection of interconnected molecular cascades that detect, transduce, and respond to changes in cellular redox status, primarily arising from reactive oxygen species (ROS) or reactive nitrogen species (RNS) production. Major pathways include the Nrf2-antioxidant response element (ARE) pathway, MAP kinase cascades, and various transcriptional and enzymatic regulators such as superoxide dismutase, catalase, and glutathione systems. These pathways regulate stress adaptation, apoptosis, cell cycle progression, and cellular antioxidant defenses. Dysregulation is implicated in diverse diseases including cancer, neurodegenerative disorders, cardiovascular and metabolic diseases. No single molecule constitutes "oxidative stress-related signaling pathways"—rather, it is a broad term for multiple targets.
For components, includes modulation of antioxidant response, ROS scavenging, enzyme induction (e.g., Nrf2 activators)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidative stress-related signaling pathways.